Publications by authors named "Kelli Ober"

Claim this Profile
J
J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of Exotoxin A.
Seth H Pincus, Kun Luo, Tami Peters, James T Gordy, Frances M Cole, Kelli Ober

Pharmaceuticals (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate.
Seth H Pincus, Frances M Cole, Kelli Ober, Monika Tokmina-Lukaszewska, Tamera Marcotte

J Virol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble CD4 and low molecular weight CD4-mimetic compounds sensitize cells to be killed by anti-HIV cytotoxic immunoconjugates.
Seth H Pincus, Megan Stackhouse, Connie Watt, Kelli Ober, Frances M Cole

J Virol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis